Skip to main content

Table 1 Clinical and pathological characteristics of patients with HCC (n = 54)

From: Targeting protein arginine methyltransferase 5 inhibits human hepatocellular carcinoma growth via the downregulation of beta-catenin

Characteristics

n

%

PRMT5 score

P value

Gender

 Male

48

88.9

3.8542

0.369

 Female

6

11.1

3.3333

 

Age (years)

 ≤50

17

31.5

3.2059

0.034

 >50

37

68.5

4.0135

 

Tumor size (cm)

 ≤5

27

50

3.8611

0.573

 >5

27

50

3.6574

 

TNM stage

 I

6

11.1

4.0833

0.259

 II

37

68.5

3.6757

 

 III

11

20.4

8.8636